Latest news
Osteosarcoma ADC breakthrough sparks race as SOT106 readies trials and deals - CHOSUNBIZ - ChosunbizChosunbiz · Thu, 06 Aug 2026 21:01:00 GMTRisvutatug Rezetecan Improves PFS in Phase 3 Osteosarcoma Trial - Targeted OncologyTargeted Oncology · Thu, 30 Jul 2026 07:00:00 GMTRis-Rez Hits PFS End Point in Phase 3 Osteosarcoma Trial - CancerNetworkCancerNetwork · Tue, 28 Jul 2026 16:08:35 GMTRis-Rez Meets Phase 3 Efficacy End Point for R/R Osteosarcoma - OncLiveOncLive · Tue, 28 Jul 2026 15:50:13 GMTGSK partner Hansoh reports another phase 3 win for priority ADC - Fierce BiotechFierce Biotech · Tue, 28 Jul 2026 12:20:00 GMTHansoh Pharma says osteosarcoma treatment drug meets primary endpoint in late stage trial - 101 WIXX101 WIXX · Tue, 28 Jul 2026 11:46:48 GMTGSK’s licensor Hansoh Pharma announces positive results from a second phase III trial for Ris-Rez in China - GSKGSK · Tue, 28 Jul 2026 07:00:00 GMTGSK, Hansoh's bone cancer drug meets main goal in late-stage trial - ReutersReuters · Tue, 28 Jul 2026 07:00:00 GMT